Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2011 17:31 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the Cowen and Company 31st Annual Healthcare Conference

EpiCept to Present at the Cowen and Company 31st Annual Healthcare Conference TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and...
March 03, 2011 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Identifies Ceplene® Survival Benefit in Key AML Subgroup

EpiCept Identifies Ceplene® Survival Benefit in Key AML Subgroup Files New Patent Applications for Ceplene® in AML of Monocyte Origin TARRYTOWN, N.Y.--(BUSINESS...
February 24, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Fourth Quarter and Full Year 2010 Operating and Financial Results

EpiCept Reports Fourth Quarter and Full Year 2010 Operating and Financial Results Conference Call to Be Held at 9:00 A.M. Eastern Time Today TARRYTOWN, N.Y.--(BUSINESS...
February 23, 2011 18:00 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at The Wall Street Analyst Forum 22nd Annual Investor Conference

EpiCept to Present at The Wall Street Analyst Forum 22nd Annual Investor Conference TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq...
February 18, 2011 17:30 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report Fourth Quarter and Full Year 2010 Operating and Financial Results on February 24, 2011

EpiCept to Report Fourth Quarter and Full Year 2010 Operating and Financial Results on February 24, 2011 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept...
February 16, 2011 16:08 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference on February 17

EpiCept to Present at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference on February 17 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept...
February 09, 2011 17:06 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the 13th Annual BIO CEO & Investor Conference

EpiCept to Present at the 13th Annual BIO CEO & Investor Conference TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX...
February 07, 2011 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy

EpiCept Reports Positive Results from EpiCept™ NP-1 Trial in Patients with Chemotherapy-Induced Peripheral Neuropathy All Primary Endpoints Met with Statistical Significance TARRYTOWN,...
January 06, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at Two Upcoming Industry Conferences

EpiCept to Present at Two Upcoming Industry Conferences TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
January 03, 2011 00:05 ET | Source: Immune Pharmaceuticals Inc

EpiCept Regains Compliance With Nasdaq's Minimum Market Value of Listed Securities

EpiCept Regains Compliance With Nasdaq's Minimum Market Value of Listed Securities TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq...